Literature DB >> 24972907

Clinical case management for patients with schizophrenia with high care needs.

Laia Mas-Expósito1, Juan Antonio Amador-Campos, Juana Gómez-Benito, Lluís Mauri-Mas, Lluís Lalucat-Jo.   

Abstract

The aim of this study is to establish the effectiveness of a clinical case management (CM) programme compared to a standard treatment programme (STP) in patients with schizophrenia. Patients for the CM programme were consecutively selected among patients in the STP with schizophrenia who had poor functioning. Seventy-five patients were admitted to the CM programme and were matched to 75 patients in the STP. Patients were evaluated at baseline and at 1 year follow-up. At baseline, patients in the CM programme showed lower levels of clinical and psychosocial functioning and more care needs than patients in the STP. Both treatment programmes were effective in maintaining contact with services but the CM programme did not show advantages over the STP on outcomes. Differences between groups at baseline may be masking the effects of CM at one year follow-up. A longer follow-up may be required to evaluate the real CM practices effects.

Entities:  

Mesh:

Year:  2014        PMID: 24972907     DOI: 10.1007/s10597-014-9741-8

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  27 in total

1.  A meta-analysis of the effectiveness of mental health case management over 20 years.

Authors:  S J Ziguras; G W Stuart
Journal:  Psychiatr Serv       Date:  2000-11       Impact factor: 3.084

Review 2.  Schizophrenia treatment: content versus delivery.

Authors:  J van Os
Journal:  Acta Psychiatr Scand Suppl       Date:  2009

3.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

4.  The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia.

Authors:  Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo
Journal:  Qual Life Res       Date:  2011-02-03       Impact factor: 4.147

Review 5.  Models of community care for severe mental illness: a review of research on case management.

Authors:  K T Mueser; G R Bond; R E Drake; S G Resnick
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

6.  Validation of the modified DUKE-UNC Functional Social Support Questionnaire in patients with schizophrenia.

Authors:  Laia Mas-Expósito; Juan Antonio Amador-Campos; Juana Gómez-Benito; Lluís Lalucat-Jo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-12-11       Impact factor: 4.328

7.  Clinical case management of revolving door patients - a semi-randomized study.

Authors:  P Lichtenberg; D Levinson; Y Sharshevsky; D Feldman; M Lachman
Journal:  Acta Psychiatr Scand       Date:  2008-03-10       Impact factor: 6.392

8.  Utilisation of mental health services and costs of patients with schizophrenia in three areas of Spain.

Authors:  J M Haro; L Salvador-Carulla; J Cabasés; V Madoz; J L Vázquez-Barquero
Journal:  Br J Psychiatry       Date:  1998-10       Impact factor: 9.319

9.  The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness.

Authors:  M Phelan; M Slade; G Thornicroft; G Dunn; F Holloway; T Wykes; G Strathdee; L Loftus; P McCrone; P Hayward
Journal:  Br J Psychiatry       Date:  1995-11       Impact factor: 9.319

Review 10.  Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression.

Authors:  Tom Burns; Jocelyn Catty; Michael Dash; Chris Roberts; Austin Lockwood; Max Marshall
Journal:  BMJ       Date:  2007-07-13
View more
  1 in total

1.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.